The global aesthetic market is shifting toward at-home medical-grade intervention. As a leader in collagen-boosting technology, EARTS integrates 300+ patents into devices that stimulate fibroblast activity, effectively reversing skin aging. Our engineering roadmap leverages RF, EMS, and Photonic therapy to provide non-invasive, high-impact results.
The future of collagen boosting lies in AI-driven diagnostic sensors. Our R&D team is currently developing smart-skin analysis chips that adjust RF intensity in real-time, ensuring optimal thermal energy delivery without tissue damage. This represents our commitment to "Information Gain"—using data to provide superior user outcomes.
Operating under strict CE, NMPA, FDA, and ROHS protocols, EARTS ensures that every factory-to-market supply chain is fully documented and audit-ready. We provide localized support, ensuring that our partners in Europe, Asia, and the Americas navigate regulatory landscapes with ease.
With 17 years of experience, we offer an all-in-one R&D-to-production solution with over 600+ global certifications.
Yes, we specialize in OEM/ODM services, including custom firmware, casing, and UI localization for diverse market needs.
We provide sample delivery within 3 days and offer streamlined mass production validation.